ArticleMicrosystems & nanoengineering2026
Boron-doped diamond solution-gate field-effect transistor (BDD-SGFET) biosensor for gene mutation detection.
Article in Microsystems & nanoengineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Gene mutation is one of the core pathogenic factors in numerous major diseases, making the detection of base mismatches resulting from these mutations critically important in both biological and clinical contexts. This study presents a high-performance boron-doped diamond solution-gated field-effect transistor (BDD-SGFET) biosensor, designed with a diamond microwire structure, for the label-free detection of base mismatches associated with EGFR gene mutations. The simulations examining the impact of variations in diamond microwire dimensions on the electrical properties of BDD-SGFET reveal that increasing the microwire width while reducing its length enhances the electrical performance of the device. Utilizing microwave plasma chemical vapor deposition (MPCVD), photolithography, and plasma etching, we successfully fabricated high-performance BDD-SGFETs featuring microwire structures that demonstrate outstanding transconductance, a reduced threshold voltage, and a limit of detection of 10 pM. Notably, the enhanced performance of the fabricated BDD-SGFET enables the successful identification of DNA molecules with two base-pair mismatches. Furthermore, the device exhibits impressive anti-interference capabilities and exceptional stability in complex environments. These findings highlight the significant potential of microscale BDD-SGFETs as rapid, label-free, and robust platforms for point-of-care testing in genetic mutation analysis pertinent to cancer diagnosis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.